"5 Monitoring and Ongoing Evaluation
All patients with AHF should be monitored for symptoms and signs, heart rate and rhythm, respiratory rate, blood pressure and SpO2 changes. Strictly control and record the amount of fluid in and out. Daily weighing can be performed if conditions permit, dynamic monitoring of renal function, blood lactate and electrolytes, and repeated evaluation of the patient's congestion evidence and volume status.
Non-invasive hemodynamic monitoring (non-invasive hemodynamic monitoring) methods include bioimpedance method, continuous Doppler cardiac output monitor (ultrasonic cardiac output monitors, USCOM), etc., which are safe and convenient to use, easy for patients to accept, and can obtain partial cardiac output. Vascular function parameters ; invasive monitoring includes central venous pressure (CVP), intra-arterial blood pressure, pulmonary artery catheter (Swan-ganz), pulse index continuous cardiac output (PiCCO), etc."
- Forums
- ASX - By Stock
- UCM
- Ann: China Guidelines Recommend USCOM for Acute HF Monitoring
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

Ann: China Guidelines Recommend USCOM for Acute HF Monitoring, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 1351000 | 0.013 |
2 | 215603 | 0.012 |
2 | 400099 | 0.010 |
1 | 150000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online